Comparison of microsomal drug hydroxylation in lung and liver of various species
Oppelt, W.W.; Zange, M.; Ross, W.E.; Remmer, H.
Research Communications in Chemical Pathology and Pharmacology 1(1): 43-56
1970
ISSN/ISBN: 0034-5164 PMID: 5524315 Document Number: 25577
Document emailed within 1 workday
Related Documents
Leibman, K.C.; Ortiz, E. 1978: Microsomal metabolism of cyclohexene. Hydroxylation in the allylic position Drug Metabolism and Disposition: the Biological Fate of Chemicals 6(4): 375-378Srivastava, G.; Bhatnagar, R.; Viswanathan, R.; Venkitasubramanian, T.A. 1980: Microsomal and mitochondrial cytochromes in acutely hypoxic rat lung and liver Indian Journal of Biochemistry and Biophysics 17(2): 130-134
Cohen, G.M.; Mannering, G.J. 1973: Involvement of a hydrophobic site in the inhibition of the microsomal p-hydroxylation of aniline by alcohols Molecular Pharmacology 9(3): 383-397
Wahle, K.W.; Davies, N.T.; Paterson, S.M. 1977: Omega-Hydroxylation of fatty acids by microsomal preparations from rat and sheep tissues Proceedings of the Nutrition Society 36(1): 30a
Il'chenko, A.P.; Sokolov, G.V. 1980: Effect of inhibitors of microsomal hydroxylation on endogenous respiration of Torulopsis candida cells Mikrobiologiia 49(5): 664-668
Prough, R.A.; Patrizi, V.W.; Okita, R.T.; Masters, B.S.; Jakobsson, S.W. 1979: Characteristics of benzo(a)pyrene metabolism by kidney, liver and lung microsomal fractions from rodents and humans Cancer Research 39(4): 199-206
Jondorf, W.R.; Donahue, J.D. 1970: The post-mortem diminution of rat liver microsomal protein synthesizing and drug metabolizing activities Research Communications in Chemical Pathology and Pharmacology 1(5): 581-590
Sabljić, A.; Protić-Sabljić, M. 1983: Quantitative structure-activity study on the mechanism of inhibition of microsomal p-hydroxylation of aniline by alcohols. Role of steric factors Molecular Pharmacology 23(1): 213-218
Kratz, F. 1978: Microsomal oxidative foreign-substance degradation by the human liver. Oxidative foreign-substance degradation by microsomal fractions of the liver withdrawn by needle biopsy, illustrated on the example of coumarin-7-hydroxylase and 7-ethoxycoumarin hydroxylase in persons with healthy livers and various liver diseases Fortschritte der Medizin 96(8): 393-397
Kurata, N.; Yoshida, T.; Kuroiwa, Y.; Masuko, T.; Hashimoto, Y. 1989: Long-term effects of phenobarbital on rat liver microsomal drug-metabolizing enzymes and heme-metabolizing enzyme Research Communications in Chemical Pathology and Pharmacology 65(2): 161-179
Yamazoe, Y.; Kamataki, T.; Kato, R. 1981: Species difference in N-hydroxylation of a tryptophan pyrolysis product in relation to mutagenic activation Cancer Research 41(11 Part 1): 4518-4522
Carter, J.M.; Driscoll, K.E. 2001: The role of inflammation, oxidative stress, and proliferation in silica-induced lung disease: a species comparison Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 20(Suppl): 33-43
Dogterom, P.; Rothuizen, J. 1993: A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences Drug Metabolism and Disposition: the Biological Fate of Chemicals 21(4): 705-709
Khakimov, Z.Z.; Krakovskiĭ, M.E. 1990: The correction of disorders in the microsomal oxidation system of the liver in experimental acute liver failure Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 1990(1): 21-23
Mori, Y.; Konishi, Y. 1991: Participation of phenobarbital-inducible cytochrome P450 in the mutagenic activation of N-nitrosopropylamines by liver and lung 9000 g fractions from five animal species and man Iarc Scientific Publications 105: 398-403
Sum, C.Y.; Cho, A.K. 1977: The N-hydroxylation of phentermine by rat liver microsomes Drug Metabolism and Disposition: the Biological Fate of Chemicals 5(5): 464-468
Dybing, E. 1976: Organ and species differences in microsomal activation of methyldopa Drug Metabolism and Disposition: the Biological Fate of Chemicals 4(6): 513-516
Tatematsu, M.; Nakanishi, K.; Murasaki, G.; Miyata, Y.; Hirose, M.; Ito, N. 1979: Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N-2-fluorenylacetamide in rats Journal of the National Cancer Institute 63(6): 1411-1416
Ramsdell, H.S.; Eaton, D.L. 1990: Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation Cancer Research 50(3): 615-620
Stevens, J.C.; White, R.B.; Hsu, S.H.; Martinet, M. 1997: Human liver CYP2B6-catalyzed hydroxylation of RP 73401 Journal of Pharmacology and Experimental Therapeutics 282(3): 1389-1395